Diagnostic performance of a whole-body dynamic 68GA-DOTATOC PET/CT acquisition to differentiate physiological uptake of pancreatic uncinate process from pancreatic neuroendocrine tumor

被引:7
|
作者
Thuillier, Philippe [1 ,2 ]
Bourhis, David [2 ,3 ]
Karakatsanis, Nicolas [4 ]
Schick, Ulrike [5 ]
Metges, Jean Philippe [6 ]
Salaun, Pierre-Yves [2 ,3 ]
Kerlan, Veronique [1 ,2 ]
Abgral, Ronan [2 ,3 ]
机构
[1] Univ Hosp Brest, Dept Endocrinol, Blvd Tanguy Prigent, F-29609 Brest, France
[2] Univ Hosp Brest, EA GETBO 3878, Brest, France
[3] Univ Hosp Brest, Dept Nucl Med, Brest, France
[4] Cornell Univ, Weil Cornell Med Coll, Dept Radiol, Div Radiopharmaceut Sci, New York, NY 10021 USA
[5] Univ Hosp Brest, Dept Radiotherapy, Brest, France
[6] Univ Hosp Brest, Dept Oncol, Brest, France
关键词
Ga-68-DOTATOC PET; Ki; neuroendocrine tumor; pancreatic uncinate process; somatostatin receptor expression; SUVmax; DOTA-NOC; SOMATOSTATIN; GA-68-DOTATOC; QUANTIFICATION; PARAMETERS; RECEPTORS; IMAGE;
D O I
10.1097/MD.0000000000020021
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To evaluate the diagnostic performance of net influx rate (Ki) values from a whole-body dynamic (WBD)Ga-68-DOTATOC-PET/CT acquisition to differentiate pancreatic neuroendocrine tumors (pNETs) from physiological uptake of pancreatic uncinate process (UP). Patients who were benefited from a WBD acquisition for the assessment of a known well-differentiated neuroendocrine tumor (NET)/suspicion of disease in the prospective GAPET-NET cohort were screened. Only patients with a confirmed pNET/UP as our gold standard were included. The positron emission tomography (PET) procedure consisted in a single-bed dynamic acquisition centered on the heart, followed by a whole-body dynamic acquisition and then a static acquisition. Dynamic (Ki calculated according to Patlak method), static (SUVmax, SUVmean, SUVpeak) parameters, and tumor-to-liver and tumor-to-spleen ratio (TLRKi and TSRKi (according to hepatic/splenic Ki)), tumor SUVmax to liver SUVmax (TM/LM), tumor SUVmax to liver SUVmean (TM/Lm), tumor SUVmax to spleen SUVmax (TM/SM), and tumor SUVmax to spleen SUVmean (TM/Sm) (according to hepatic/splenic SUVmax and SUVmean respectively) were calculated. A Receiver Operating Characteristic (ROC) analysis was performed to evaluate their diagnostic performance to distinguish UP from pNET. One hundred five patients benefited from a WBD between July 2018 and July 2019. Eighteen (17.1%) had an UP and 26 (24.8%) a pNET. For parameters alone, the Ki and SUVpeak had the best sensitivity (88.5%) while the Ki, SUVmax, and SUVmean had the best specificity (94.4%). The best diagnostic accuracy was obtained with Ki (90.9%). For ratios, the TLRKi and the TSRKi had the best sensitivity (95.7%) while the TM/SM and TM/Sm the best specificity (100%). TLRKi had the best diagnostic accuracy (95.1%) and the best area under the curve (AUC) (0.990). Our study is the first one to evaluate the interest of a WBD acquisition to differentiate UP from pNETs and shows excellent diagnostic performances of the Ki approach.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Dynamic whole-body 68Ga-DOTATOC PET/CT
    Lodge, Martin
    Rahmim, Arman
    Antoniou, Alexander
    Solnes, Lilja
    Wahl, Richard
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [2] Evaluation of 68Ga-DOTATOC PET/MRI for whole-body staging of neuroendocrine tumours in comparison with 68Ga-DOTATOC PET/CT
    Lino M. Sawicki
    Cornelius Deuschl
    Karsten Beiderwellen
    Verena Ruhlmann
    Thorsten D. Poeppel
    Philipp Heusch
    Harald Lahner
    Dagmar Führer
    Andreas Bockisch
    Ken Herrmann
    Michael Forsting
    Gerald Antoch
    Lale Umutlu
    European Radiology, 2017, 27 : 4091 - 4099
  • [3] Evaluation of 68Ga-DOTATOC PET/MRI for whole-body staging of neuroendocrine tumours in comparison with 68Ga-DOTATOC PET/CT
    Sawicki, Lino M.
    Deuschl, Cornelius
    Beiderwellen, Karsten
    Ruhlmann, Verena
    Poeppel, Thorsten D.
    Heusch, Philipp
    Lahner, Harald
    Fuehrer, Dagmar
    Bockisch, Andreas
    Herrmann, Ken
    Forsting, Michael
    Antoch, Gerald
    Umutlu, Lale
    EUROPEAN RADIOLOGY, 2017, 27 (10) : 4091 - 4099
  • [4] Serous cystadenoma mimicking cystic pancreatic neuroendocrine tumor on 68Ga-DOTATOC PET/CT
    Passand, Goudarz T.
    Marichez, Arthur
    Debordeaux, Eric
    Pinaquy, Jean-Baptiste
    Chiche, Laurence
    DIAGNOSTIC AND INTERVENTIONAL IMAGING, 2022, 103 (11) : 563 - 565
  • [5] 18F-FDG PET/CT and 68Ga-DOTATOC PET/CT in Diffuse Pancreatic Neuroendocrine Tumor
    Ji, Xia
    Dong, Aisheng
    He, Qi
    Dong, Hui
    Zuo, Changjing
    CLINICAL NUCLEAR MEDICINE, 2020, 45 (05) : E245 - E248
  • [6] Determinants of the uptake of the uncinate process of pancreas in 68Ga-DOTATOC PET/CT: a retrospective study
    Jallet, Lucas
    Othmani, Wadi'
    Perrier, Marine
    Morland, David
    ENDOCRINE, 2024, 85 (01) : 392 - 397
  • [7] 68GA-DOTATOC PET/CT IMAGES REPRESENT THE CLINICAL CHARACTERISTICS OF PANCREATIC NEUROENDOCRINE TUMORS
    Kim, So Jeong
    Cha, Jongtae
    Lee, Hee Seung
    Chung, Moon Jae
    Park, Jeong Youp
    Bang, Seungmin
    Park, Seung Woo
    Song, Si Young
    Cho, Arthur
    Jo, Jung Hyun
    GASTROENTEROLOGY, 2023, 164 (06) : S323 - S324
  • [8] Role of 68Ga-DOTATOC PET-CT in the diagnosis and staging of pancreatic neuroendocrine tumours
    Rakesh Kumar
    Punit Sharma
    Pramod Garg
    Sellam Karunanithi
    Niraj Naswa
    Raju Sharma
    Sanjay Thulkar
    Sneh Lata
    Arun Malhotra
    European Radiology, 2011, 21 : 2408 - 2416
  • [9] Role of 68Ga-DOTATOC PET-CT in the diagnosis and staging of pancreatic neuroendocrine tumours
    Kumar, Rakesh
    Sharma, Punit
    Garg, Pramod
    Karunanithi, Sellam
    Naswa, Niraj
    Sharma, Raju
    Thulkar, Sanjay
    Lata, Sneh
    Malhotra, Arun
    EUROPEAN RADIOLOGY, 2011, 21 (11) : 2408 - 2416
  • [10] Diagnostic performance of 68Ga-DOTATOC PET/CT in tumor-induced osteomalacia
    Kato, Ayako
    Nakamoto, Yuji
    Ishimori, Takayoshi
    Hayakawa, Nobuyuki
    Ueda, Masashi
    Temma, Takashi
    Sano, Kohei
    Shimizu, Yoichi
    Saga, Tsuneo
    Togashi, Kaori
    ANNALS OF NUCLEAR MEDICINE, 2021, 35 (03) : 397 - 405